Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 6, Number 18, 2000

Book Reviews

Preface
pp. i-i(1)
Authors: Kozikowski, A.P.; Baraldi, P.G.

Favourites:
ADD

Reviews

Structure-based Design of Compounds Inhibiting Grb2-SH2 Mediated Protein-protein Interactions in Signal Transduction Pathways
pp. 1777-1796(20)
Authors: Fretz, H.; Furet, P.; Echeverria, C.G.; Rahuel, J.; Schoepfer, J.

Favourites:
ADD
Favourites:
ADD

Antitumor Properties of Podophyllotoxin and Related Compounds.
pp. 1811-1839(29)
Authors: Gordaliza, M.; Castro, M.A.; Miguel del Corral, J.M.; Feliciano, A.S.

Favourites:
ADD

Understanding and Exploiting Nature's Chemical Arsenal: The Past, Present and Future of Calicheamicin Research.
pp. 1841-1879(39)
Authors: Thorson, J.S.; Sievers, E.L.; Ahlert, J.; Shepard, E.; Whitwam, R.E.; Onwueme, K.C.; Ruppen, M.

Favourites:
ADD

Mucins in the Diagnosis and Therapy of Pancreatic Cancer.
pp. 1881-1896(16)
Author: Ho, J.J.L.

Favourites:
ADD

Fibroblast Growth Factors and Their Inhibitors
pp. 1897-1924(28)
Authors: Manetti, F.; Corelli, F.; Botta, M.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content